Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1.

Gur C, Maalouf N, Shhadeh A, Berhani O, Singer BB, Bachrach G, Mandelboim O.

Oncoimmunology. 2019 Mar 27;8(6):e1581531. doi: 10.1080/2162402X.2019.1581531. eCollection 2019.

PMID:
31069151
2.

The Helicobacter pylori HopQ outermembrane protein inhibits immune cell activities.

Gur C, Maalouf N, Gerhard M, Singer BB, Emgård J, Temper V, Neuman T, Mandelboim O, Bachrach G.

Oncoimmunology. 2019 Jan 29;8(4):e1553487. doi: 10.1080/2162402X.2018.1553487. eCollection 2019.

PMID:
30906650
3.

Learning from experience: cellular and molecular bases for improved outcome in subsequent pregnancies.

Goldman-Wohl D, Gamliel M, Mandelboim O, Yagel S.

Am J Obstet Gynecol. 2019 Feb 22. pii: S0002-9378(19)30389-8. doi: 10.1016/j.ajog.2019.02.037. [Epub ahead of print] Review.

PMID:
30802436
4.

A BW Reporter System for Studying Receptor-Ligand Interactions.

Elias S, Kahlon S, Duev-Cohen A, Mandelboim O.

J Vis Exp. 2019 Jan 7;(143). doi: 10.3791/58685.

PMID:
30663643
5.

IFNG-AS1 Enhances Interferon Gamma Production in Human Natural Killer Cells.

Stein N, Berhani O, Schmiedel D, Duev-Cohen A, Seidel E, Kol I, Tsukerman P, Hecht M, Reches A, Gamliel M, Obeidat A, Charpak-Amikam Y, Yamin R, Mandelboim O.

iScience. 2019 Jan 25;11:466-473. doi: 10.1016/j.isci.2018.12.034. Epub 2019 Jan 3.

6.

Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research.

Berhani O, Glasner A, Kahlon S, Duev-Cohen A, Yamin R, Horwitz E, Enk J, Moshel O, Varvak A, Porgador A, Jonjic S, Mandelboim O.

Eur J Immunol. 2019 Feb;49(2):228-241. doi: 10.1002/eji.201847611. Epub 2018 Dec 17.

PMID:
30536875
7.

Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1.

Obiedat A, Seidel E, Mahameed M, Berhani O, Tsukerman P, Voutetakis K, Chatziioannou A, McMahon M, Avril T, Chevet E, Mandelboim O, Tirosh B.

FASEB J. 2019 Mar;33(3):3481-3495. doi: 10.1096/fj.201801350RR. Epub 2018 Nov 19.

PMID:
30452881
8.

Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Kučan Brlić P, Lenac Roviš T, Cinamon G, Tsukerman P, Mandelboim O, Jonjić S.

Cell Mol Immunol. 2019 Jan;16(1):40-52. doi: 10.1038/s41423-018-0168-y. Epub 2018 Oct 1.

PMID:
30275538
9.

NKG2D Ligands-Critical Targets for Cancer Immune Escape and Therapy.

Schmiedel D, Mandelboim O.

Front Immunol. 2018 Sep 11;9:2040. doi: 10.3389/fimmu.2018.02040. eCollection 2018. Review.

10.

Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency.

Rätsep MT, Moore SD, Jafri S, Mitchell M, Brady HJM, Mandelboim O, Southwood M, Morrell NW, Colucci F, Ormiston ML.

Am J Physiol Lung Cell Mol Physiol. 2018 Dec 1;315(6):L977-L990. doi: 10.1152/ajplung.00477.2017. Epub 2018 Sep 20.

11.

Sweet Killers: NK Cells Need Glycolysis to Kill Tumors.

Isaacson B, Mandelboim O.

Cell Metab. 2018 Aug 7;28(2):183-184. doi: 10.1016/j.cmet.2018.07.008.

PMID:
30089237
12.

The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells.

Edri A, Shemesh A, Iraqi M, Matalon O, Brusilovsky M, Hadad U, Radinsky O, Gershoni-Yahalom O, Dye JM, Mandelboim O, Barda-Saad M, Lobel L, Porgador A.

Front Immunol. 2018 Jul 2;9:1428. doi: 10.3389/fimmu.2018.01428. eCollection 2018.

13.

The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.

Dassa L, Seidel E, Oiknine-Djian E, Yamin R, Wolf DG, Le-Trilling VTK, Mandelboim O.

J Virol. 2018 Aug 16;92(17). pii: e00162-18. doi: 10.1128/JVI.00162-18. Print 2018 Sep 1.

14.

Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL).

Elias S, Kahlon S, Kotzur R, Kaynan N, Mandelboim O.

Oncoimmunology. 2018 Feb 12;7(6):e1428158. doi: 10.1080/2162402X.2018.1428158. eCollection 2018.

15.

Trained Memory of Human Uterine NK Cells Enhances Their Function in Subsequent Pregnancies.

Gamliel M, Goldman-Wohl D, Isaacson B, Gur C, Stein N, Yamin R, Berger M, Grunewald M, Keshet E, Rais Y, Bornstein C, David E, Jelinski A, Eisenberg I, Greenfield C, Ben-David A, Imbar T, Gilad R, Haimov-Kochman R, Mankuta D, Elami-Suzin M, Amit I, Hanna JH, Yagel S, Mandelboim O.

Immunity. 2018 May 15;48(5):951-962.e5. doi: 10.1016/j.immuni.2018.03.030.

16.

Quantification of Bacterial Attachment to Tissue Sections.

Isaacson B, Hadad T, Bachrach G, Mandelboim O.

Bio Protoc. 2018 Mar 5;8(5). pii: e2741. doi: 10.21769/BioProtoc.2741.

17.

Decay of the Stress-Induced Ligand MICA Is Controlled by the Expression of an Alternative 3' Untranslated Region.

Toledano T, Vitenshtein A, Stern-Ginossar N, Seidel E, Mandelboim O.

J Immunol. 2018 Apr 15;200(8):2819-2825. doi: 10.4049/jimmunol.1700968. Epub 2018 Mar 14.

18.

NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.

Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, Sexl V, Jonjic S, Seliger B, Zitvogel L, Mandelboim O.

Immunity. 2018 Feb 20;48(2):396-398. doi: 10.1016/j.immuni.2018.01.010. No abstract available.

19.

NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.

Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, Sexl V, Jonjic S, Seliger B, Zitvogel L, Mandelboim O.

Immunity. 2018 Jan 16;48(1):107-119.e4. doi: 10.1016/j.immuni.2017.12.007. Epub 2018 Jan 9. Erratum in: Immunity. 2018 Feb 20;48(2):396-398.

20.

Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours.

Levi-Schaffer F, Mandelboim O.

Trends Immunol. 2018 Feb;39(2):112-122. doi: 10.1016/j.it.2017.10.001. Epub 2017 Oct 20. Review.

PMID:
29066058
21.

Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression.

Glasner A, Isaacson B, Viukov S, Neuman T, Friedman N, Mandelboim M, Sexl V, Hanna JH, Mandelboim O.

Sci Rep. 2017 Oct 12;7(1):13090. doi: 10.1038/s41598-017-12998-w.

22.

Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules.

Glasner A, Oiknine-Djian E, Weisblum Y, Diab M, Panet A, Wolf DG, Mandelboim O.

J Virol. 2017 Oct 27;91(22). pii: e00785-17. doi: 10.1128/JVI.00785-17. Print 2017 Nov 15.

23.

Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20.

Charpak-Amikam Y, Kubsch T, Seidel E, Oiknine-Djian E, Cavaletto N, Yamin R, Schmiedel D, Wolf D, Gribaudo G, Messerle M, Cicin-Sain L, Mandelboim O.

Sci Rep. 2017 Aug 17;7(1):8661. doi: 10.1038/s41598-017-08866-2.

24.

NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.

Bar-On Y, Charpak-Amikam Y, Glasner A, Isaacson B, Duev-Cohen A, Tsukerman P, Varvak A, Mandelboim M, Mandelboim O.

J Virol. 2017 Sep 12;91(19). pii: e01045-17. doi: 10.1128/JVI.01045-17. Print 2017 Oct 1.

25.

Tumor Targeting by Fusobacterium nucleatum: A Pilot Study and Future Perspectives.

Abed J, Maalouf N, Parhi L, Chaushu S, Mandelboim O, Bachrach G.

Front Cell Infect Microbiol. 2017 Jun 30;7:295. doi: 10.3389/fcimb.2017.00295. eCollection 2017.

26.

Stromal Cell-Derived Factor 1 Mediates Immune Cell Attraction upon Urinary Tract Infection.

Isaacson B, Hadad T, Glasner A, Gur C, Granot Z, Bachrach G, Mandelboim O.

Cell Rep. 2017 Jul 5;20(1):40-47. doi: 10.1016/j.celrep.2017.06.034.

27.

NCR1-deficiency diminishes the generation of protective murine cytomegalovirus antibodies by limiting follicular helper T-cell maturation.

Miletic A, Lenartic M, Popovic B, Brizic I, Trsan T, Miklic K, Mandelboim O, Krmpotic A, Jonjic S.

Eur J Immunol. 2017 Sep;47(9):1443-1456. doi: 10.1002/eji.201646763. Epub 2017 Jul 21.

28.

Disarming Cellular Alarm Systems-Manipulation of Stress-Induced NKG2D Ligands by Human Herpesviruses.

Schmiedel D, Mandelboim O.

Front Immunol. 2017 Apr 11;8:390. doi: 10.3389/fimmu.2017.00390. eCollection 2017. Review.

29.

Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape.

Eichmüller SB, Osen W, Mandelboim O, Seliger B.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx034. Review.

PMID:
28383653
30.

Vigilin Regulates the Expression of the Stress-Induced Ligand MICB by Interacting with Its 5' Untranslated Region.

Berhani O, Nachmani D, Yamin R, Schmiedel D, Bar-On Y, Mandelboim O.

J Immunol. 2017 May 1;198(9):3662-3670. doi: 10.4049/jimmunol.1601589. Epub 2017 Mar 29.

31.

NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection.

Diab M, Glasner A, Isaacson B, Bar-On Y, Drori Y, Yamin R, Duev-Cohen A, Danziger O, Zamostiano R, Mandelboim M, Jonjic S, Bacharach E, Mandelboim O.

Eur J Immunol. 2017 Apr;47(4):692-703. doi: 10.1002/eji.201646756. Epub 2017 Mar 6.

32.

Expression and function of NKp46 W32R: the human homologous protein of mouse NKp46 W32R (Noé).

Glasner A, Isaacson B, Mandelboim O.

Sci Rep. 2017 Jan 30;7:40944. doi: 10.1038/srep40944.

33.

The paired receptors TIGIT and DNAM-1 as targets for therapeutic antibodies.

Stein N, Tsukerman P, Mandelboim O.

Hum Antibodies. 2017;25(3-4):111-119. doi: 10.3233/HAB-160307. Review.

PMID:
28035916
34.

HSV1 MicroRNA Modulation of GPI Anchoring and Downstream Immune Evasion.

Enk J, Levi A, Weisblum Y, Yamin R, Charpak-Amikam Y, Wolf DG, Mandelboim O.

Cell Rep. 2016 Oct 18;17(4):949-956. doi: 10.1016/j.celrep.2016.09.077.

35.

NK Cell Recognition of Candida glabrata through Binding of NKp46 and NCR1 to Fungal Ligands Epa1, Epa6, and Epa7.

Vitenshtein A, Charpak-Amikam Y, Yamin R, Bauman Y, Isaacson B, Stein N, Berhani O, Dassa L, Gamliel M, Gur C, Glasner A, Gomez C, Ben-Ami R, Osherov N, Cormack BP, Mandelboim O.

Cell Host Microbe. 2016 Oct 12;20(4):527-534. doi: 10.1016/j.chom.2016.09.008.

36.

Suppression of human metapneumovirus (HMPV) infection by the innate sensing gene CEACAM1.

Diab M, Vitenshtein A, Drori Y, Yamin R, Danziger O, Zamostiano R, Mandelboim M, Bacharach E, Mandelboim O.

Oncotarget. 2016 Oct 11;7(41):66468-66479. doi: 10.18632/oncotarget.11979.

37.

Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells.

Schmiedel D, Tai J, Levi-Schaffer F, Dovrat S, Mandelboim O.

J Virol. 2016 Oct 14;90(21):9608-9617. doi: 10.1128/JVI.01164-16. Print 2016 Nov 1.

38.

Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection.

Lenac Rovis T, Kucan Brlic P, Kaynan N, Juranic Lisnic V, Brizic I, Jordan S, Tomic A, Kvestak D, Babic M, Tsukerman P, Colonna M, Koszinowski U, Messerle M, Mandelboim O, Krmpotic A, Jonjic S.

J Exp Med. 2016 Aug 22;213(9):1835-50. doi: 10.1084/jem.20151899. Epub 2016 Aug 8.

39.

CEACAM1-Mediated Inhibition of Virus Production.

Vitenshtein A, Weisblum Y, Hauka S, Halenius A, Oiknine-Djian E, Tsukerman P, Bauman Y, Bar-On Y, Stern-Ginossar N, Enk J, Ortenberg R, Tai J, Markel G, Blumberg RS, Hengel H, Jonjic S, Wolf DG, Adler H, Kammerer R, Mandelboim O.

Cell Rep. 2016 Jun 14;15(11):2331-9. doi: 10.1016/j.celrep.2016.05.036. Epub 2016 Jun 2.

40.

HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins.

Reches A, Nachmani D, Berhani O, Duev-Cohen A, Shreibman D, Ophir Y, Seliger B, Mandelboim O.

J Immunol. 2016 Jun 15;196(12):4967-76. doi: 10.4049/jimmunol.1501550. Epub 2016 May 18.

41.

HCMV vCXCL1 Binds Several Chemokine Receptors and Preferentially Attracts Neutrophils over NK Cells by Interacting with CXCR2.

Yamin R, Lecker LSM, Weisblum Y, Vitenshtein A, Le-Trilling VTK, Wolf DG, Mandelboim O.

Cell Rep. 2016 May 17;15(7):1542-1553. doi: 10.1016/j.celrep.2016.04.042. Epub 2016 May 5.

42.

Interaction of the LILRB1 inhibitory receptor with HLA class Ia dimers.

Baía D, Pou J, Jones D, Mandelboim O, Trowsdale J, Muntasell A, López-Botet M.

Eur J Immunol. 2016 Jul;46(7):1681-90. doi: 10.1002/eji.201546149. Epub 2016 Jun 2.

43.

Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma.

Jasinski-Bergner S, Reches A, Stoehr C, Massa C, Gonschorek E, Huettelmaier S, Braun J, Wach S, Wullich B, Spath V, Wang E, Marincola FM, Mandelboim O, Hartmann A, Seliger B.

Oncotarget. 2016 May 3;7(18):26866-78. doi: 10.18632/oncotarget.8567.

44.

PILRα binds an unknown receptor expressed primarily on CD56bright and decidual-NK cells and activates NK cell functions.

Ophir Y, Duev-Cohen A, Yamin R, Tsukerman P, Bauman Y, Gamliel M, Mandelboim O.

Oncotarget. 2016 Jul 5;7(27):40953-40964. doi: 10.18632/oncotarget.8397.

45.

Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity.

Bauman Y, Drayman N, Ben-Nun-Shaul O, Vitenstein A, Yamin R, Ophir Y, Oppenheim A, Mandelboim O.

Oncotarget. 2016 Mar 29;7(13):15369-81. doi: 10.18632/oncotarget.8085.

46.

The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB.

Schmiedel D, Tai J, Yamin R, Berhani O, Bauman Y, Mandelboim O.

Elife. 2016 Mar 16;5. pii: e13426. doi: 10.7554/eLife.13426.

47.

Pregnancy-specific glycoprotein expression in normal gastrointestinal tract and in tumors detected with novel monoclonal antibodies.

Houston A, Williams JM, Rovis TL, Shanley DK, O'Riordan RT, Kiely PA, Ball M, Barry OP, Kelly J, Fanning A, MacSharry J, Mandelboim O, Singer BB, Jonjic S, Moore T.

MAbs. 2016;8(3):491-500. doi: 10.1080/19420862.2015.1134410. Epub 2016 Feb 29. Erratum in: MAbs. 2018 Aug/Sep;10(6):944.

48.

The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity.

Duev-Cohen A, Bar-On Y, Glasner A, Berhani O, Ophir Y, Levi-Schaffer F, Mandelboim M, Mandelboim O.

Oncotarget. 2016 Mar 15;7(11):13093-105. doi: 10.18632/oncotarget.7597.

49.

Cytokine secretion and NK cell activity in human ADAM17 deficiency.

Tsukerman P, Eisenstein EM, Chavkin M, Schmiedel D, Wong E, Werner M, Yaacov B, Averbuch D, Molho-Pessach V, Stepensky P, Kaynan N, Bar-On Y, Seidel E, Yamin R, Sagi I, Elpeleg O, Mandelboim O.

Oncotarget. 2015 Dec 29;6(42):44151-60. doi: 10.18632/oncotarget.6629.

50.

Identification and Analysis of Natural Killer Cells in Murine Nasal Passages.

Okada K, Sato S, Sato A, Mandelboim O, Yamasoba T, Kiyono H.

PLoS One. 2015 Nov 17;10(11):e0142920. doi: 10.1371/journal.pone.0142920. eCollection 2015.

Supplemental Content

Loading ...
Support Center